Usdan Adam

CIK 00014591071 companyNEW YORK,, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001459107

Recent Transactions

50 trades

Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-05-25$0.13/sh−1,435,000→ 18,938,485 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-05-25$0.13/sh−1,435,000→ 18,938,485 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-05-24$0.16/sh−300,000→ 20,373,485 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-05-24$0.16/sh−300,000→ 20,373,485 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-03-31$0.08/sh−36,000→ 21,371,379 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-03-31$0.08/sh−36,000→ 21,371,379 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-03-31$0.08/sh−36,000→ 21,371,379 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-03-31$0.08/sh−36,000→ 21,371,379 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-03-31$0.08/sh−36,000→ 21,371,379 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-03-31$0.08/sh−36,000→ 21,371,379 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-12-30$0.04/sh−170,000→ 22,245,571 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-12-30$0.04/sh−170,000→ 22,245,571 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-12-30$0.04/sh−170,000→ 22,245,571 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-12-30$0.04/sh−170,000→ 22,245,571 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-12-30$0.04/sh−170,000→ 22,245,571 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-12-30$0.04/sh−170,000→ 22,245,571 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-30$0.08/sh−119,219→ 23,195,758 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-30$0.08/sh−119,219→ 23,195,758 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-30$0.08/sh−119,219→ 23,195,758 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-30$0.08/sh−119,219→ 23,195,758 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-30$0.08/sh−119,219→ 23,195,758 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-29$0.08/sh−76,800→ 23,314,977 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-29$0.08/sh−76,800→ 23,314,977 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-29$0.08/sh−76,800→ 23,314,977 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-29$0.08/sh−76,800→ 23,314,977 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2010-04-29$0.08/sh−76,800→ 23,314,977 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-31$0.11/sh−212,500→ 23,989,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-31$0.11/sh−212,500→ 23,989,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-31$0.11/sh−212,500→ 23,989,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-31$0.11/sh−212,500→ 23,989,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-31$0.11/sh−212,500→ 23,989,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-30$0.11/sh−80,750→ 24,201,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-30$0.11/sh−80,750→ 24,201,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-30$0.11/sh−80,750→ 24,201,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-30$0.11/sh−80,750→ 24,201,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-30$0.11/sh−80,750→ 24,201,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-29$0.11/sh−39,250→ 24,282,527 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-29$0.11/sh−39,250→ 24,282,527 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-29$0.11/sh−39,250→ 24,282,527 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-29$0.11/sh−39,250→ 24,282,527 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-29$0.11/sh−39,250→ 24,282,527 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-24$0.11/sh−80,000→ 24,321,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-24$0.11/sh−80,000→ 24,321,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-24$0.11/sh−80,000→ 24,321,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-24$0.11/sh−80,000→ 24,321,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-12-24$0.11/sh−80,000→ 24,321,777 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-10-30$0.09/sh−107,500→ 26,369,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-10-30$0.09/sh−107,500→ 26,369,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-10-30$0.09/sh−107,500→ 26,369,277 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2009-10-29$0.08/sh−100,000→ 26,476,777 total

Companies

ELITE PHARMACEUTICALS INC /NV/
10% Owner
$ELTP

Recent Filings

Address

C/O TRELLUS MANAGEMENT COMPANY, LLC 350 MADISON AVENUE, 9TH FLOOR

NEW YORK,, NY, 10017

View on SEC.gov